+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

U.S. Pharmacy Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 100 Pages
  • August 2026
  • Region: United States
  • Grand View Research
  • ID: 6214498
The U.S. pharmacy market size was valued at USD 801.6 billion in 2025 and is projected to grow from USD 878.1 billion in 2026 toUSD 1.70 trillion by 2033, at a CAGR of 10.0% from 2026 to 2033. The growth is attributed to the rising prevalence of chronic diseases, the high utilization of prescription drugs, and the increasing elderly population in the country.

A report published in January 2024 by American Heart Association (AHA) highlights a significant awareness gap surrounding cardiovascular health in the U.S. Despite heart disease remaining the country’s leading cause of death for more than 100 years, 51% of surveyed U.S. adults did not identify it as the leading cause of death, while 18% incorrectly identified cancer as the leading cause. This lack of awareness is particularly concerning because cardiovascular disease affects 48.6% of the U.S. population, and 46.7% of adults have high blood pressure, with 38% of those individuals unaware of their condition.

The section below outlines the key factors driving the growth of the U.S. market for pharmacy, highlighting the rising prevalence of chronic diseases and the increasing need for prescription medications and long-term medication management. It also examines the growing adoption of specialty drugs and high-cost therapies, the expansion of pharmacy-based healthcare services such as vaccinations, chronic disease management, and medication counseling, and the increasing integration of digital technologies, ePharmacies, mail-order services, and tele-pharmacy.

U.S. Pharmacy Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. pharmacy market report based on type, product, and ownership.

Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Retail chains (e.g., Walgreens, CVS)
  • Supermarket pharmacies
  • Health system / hospital pharmacies
  • Independent pharmacies
  • Mail-order pharmacies
  • Specialty / central fill pharmacies
  • Long-term care and defense-related pharmacies
  • ePharmacy
  • Others

Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • Prescription
  • OTC

Ownership Outlook (Revenue, USD Billion, 2021 - 2033)

  • Chain
  • Independent

Country Outlook (Revenue, USD Billion, 2021 - 2033)

  • Southeast
  • Southwest
  • West
  • Midwest
  • Northeast

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

This product will be delivered within 2 business days.

Table of Contents

Chapter 1 Report Scope & Research Methodology
1.1 Market Segmentation
1.1.1 Segment Definition
1.1.1.1 Product
1.1.1.2 Type
1.1.1.3 Ownership
1.2 Estimates and Forecast Timeline
1.3 Research Methodology
1.3.1 Information Procurement
1.3.2 Purchased Database
1.3.3 The internal database
1.3.4 Secondary Sources
1.3.5 Primary Research
1.3.6 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Three Pillars of Market Estimation
1.6.1.1 Secondary Market Research
1.6.1.2 Primary Market Intelligence
1.6.1.2.1 In-Depth Interviews (IDIs)
1.6.1.2.2 Online Survey Program
1.6.2 Market Modeling & Forecasting
1.6.2.1 Model 1: Volume-Price Analysis
1.6.2.1.1 Step 1: Prescription volume estimation
1.6.2.1.2 Channel-Wise Methodology
1.6.2.1.2.1 Retail Chains (CVS, Walgreens, etc.)
1.6.2.1.2.2 Supermarket Pharmacies (Kroger, Albertsons, Publix)
1.6.2.1.2.3 Health System / Hospital Outpatient Pharmacies
1.6.2.1.2.4 Independent Pharmacies
1.6.2.1.2.5 Mail-Order Pharmacies
1.6.2.1.2.6 Specialty / Central Fill Pharmacies
1.6.2.1.2.7 Long-Term Care (LTC) and Defense-Related Pharmacies
1.6.2.1.2.8 ePharmacies (Amazon, Capsule, Hims & Hers, etc.)
1.6.2.1.2.9 Other Channels
1.6.2.1.2.10 Aggregation & Triangulation
1.6.2.1.3 Step 2: Determining Average Realized Price (ARP)
1.6.2.1.4 Step 2: OTC Revenue
1.6.2.2 Model 2: Company Market Share Analysis
1.6.2.2.1 Step 1: Public Filings
1.6.2.2.2 Step 2: Private & Independent Estimates
1.6.2.2.3 Step 3: Market Share Allocation
1.6.2.3 CAGR/Forecasting Calculations & Assumptions
1.6.2.3.1 Key Forecasting Drivers and Weights
1.6.2.3.2 Scenario Framework (2026 - 2033)
1.6.2.3.3 Factor-Based Impact Assessment
1.6.3 Estimation Process: Pharmacy Split by Catchment Area
1.6.3.1 Data Sources
1.6.3.2 Estimation Process
1.6.4 Estimation Process: Pharmacy Split by Product Form
1.6.5 Company-Level Metric’s Estimation
1.6.5.1 Financial Performance
1.6.5.1.1 2025 Revenue & EBITDA (Pharmacy-Only)
1.6.5.1.2 5-Year Forecast of Revenue & EBITDA
1.6.5.1.3 Balance Sheet Health Indicators
1.6.5.2 Volumes & Operations
1.6.5.2.1 2025 Total Prescriptions; 5-Year Rx Forecast
1.6.5.2.2 % Fulfilled via Central Fill; Volumes Split by Catchment Area
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Research Objectives
1.9.1 Objective - 1
1.9.2 Objective - 2
1.9.3 Objective - 3
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Outlook - I
2.3 Segment Outlook- II
2.4 Competitive Scenario
Chapter 3 U.S. Pharmacy Market - Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related Market Outlook
3.1.2.1 U.S. pharmacy benefit management market
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing prevalence of chronic diseases
3.2.1.2 Technological advancements
3.2.1.3 Expanding health insurance coverage
3.2.1.4 Increasing demand for specialty drugs
3.2.2 Market Restraint Analysis
3.2.2.1 Product recalls and lawsuits
3.2.2.2 Lack of trained staff
3.2.3 Market Opportunity Analysis
3.2.4 Market Challange Analysis
3.3 Regulatory Scenario & Reimbursement Outlook
3.3.1 Regulatory Scenario
3.3.2 Reimbursement Scenario
3.4 Business Environment Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 Pestle Analysis
Chapter 4 U.S. Pharmacy Market: Product Estimates & Trend Analysis
4.1 U.S. Pharmacy Market: Product Segment Dashboard
4.2 Product Movement & Market Share Analysis, 2025 & 2033
4.3 U.S. Pharmacy Market Size & Forecast and Forecasts, Product (USD Billion)
4.3.1 Prescription
4.3.1.1 Prescription market, 2021 - 2033 (USD Billion)
4.3.2 Over-the-Counter (OTC)
4.3.2.1 OTC market, 2021 - 2033 (USD Billion)
Chapter 5 U.S. Pharmacy Market: Type Estimates & Trend Analysis
5.1 U.S. Pharmacy Market: Type Segment Dashboard
5.2 Type Movement & Market Share Analysis, 2025 & 2033
5.3 U.S. Pharmacy Market Size & Forecast and Forecasts, Type, 2021 - 2033 (USD Billion)
5.4 U.S. Pharmacy Market: Estimated Number of Pharmacies, Type, 2021 - 2033 (Unit)
5.5 U.S. Pharmacy Market: Estimated Prescription Volume, Type, 2021 - 2033 (Million)
5.6 U.S. Pharmacy Market: Estimated Prescription Volume, Catchment Area, 2025 (%)
5.7 U.S. Pharmacy Market: Estimated Prescription Volume, Filled Prescriptions (TRx), 2025 (%)
5.7.1 Retail Chains
5.7.1.1 Retail chains market, 2021 - 2033 (USD Billion)
5.7.2 Supermarket Pharmacies
5.7.2.1 Supermarket pharmacies market, 2021 - 2033 (USD Billion)
5.7.3 Health System / Hospital Pharmacy
5.7.3.1 Health system / Hospital pharmacy market, 2021 - 2033 (USD Billion)
5.7.4 Independent Pharmacies
5.7.4.1 Independent pharmacies market, 2021 - 2033 (USD Billion)
5.7.5 Mail-Order Pharmacies
5.7.5.1 Mail-order pharmacy market, 2021 - 2033 (USD Billion)
5.7.6 Specialty / Central Fill Pharmacies
5.7.6.1 Specialty / central fill pharmacies market, 2021 - 2033 (USD Billion)
5.7.7 Long-Term Care And Defense-Related Pharmacies
5.7.7.1 Long-term care and defense-related pharmacies market, 2021 - 2033 (USD Billion)
5.7.8 Epharmacy
5.7.8.1 ePharmacy market, 2021 - 2033 (USD Billion)
5.7.9 Others
5.7.9.1 Others market, 2021 - 2033 (USD Billion)
Chapter 6 U.S. Pharmacy Market: Ownership Estimates & Trend Analysis
6.1 U.S. Pharmacy Market: Ownership Segment Dashboard
6.2 Ownership Movement & Market Share Analysis, 2026 & 2033
6.3 U.S. Pharmacy Market Size & Forecast and Forecasts, Ownership, 2021 - 2033 (USD Billion)
6.3.1 Chains
6.3.1.1 Chains market, 2021 - 2033 (USD Billion)
6.3.2 Independent
6.3.2.1 Independent market, 2021 - 2033 (USD Billion)"
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Specialty drug expenditures
Table 4 U.S. pharmacy market revenue estimates and forecast, product, 2021 - 2033 (USD Billion)
Table 5 U.S. pharmacy market revenue estimates and forecast, type, 2021 - 2033 (USD Billion)
Table 6 U.S. pharmacy market: Estimated number of pharmacies, type, 2021 - 2033 (Unit)
Table 7 U.S. pharmacy market: Estimated prescription volume, type, 2021 - 2033 (Million)
Table 8 U.S. pharmacy market revenue estimates and forecast, ownership, 2021 - 2033 (USD Billion)
Table 9 U.S. pharmacy market: Estimated prescription volume, catchment area, 2025 (%)
Table 10 U.S. pharmacy market: Estimated prescription volume, filled prescriptions (TRx), 2025 (%)
List of Figures
Fig.1 U.S. pharmacy market segmentation
Figure2 Market research process
Figure3 Information procurement
Figure4 Primary research pattern
Figure5 Market research approaches
Figure6 Value-chain-based sizing & forecasting
Figure7 Market formulation & validation
Figure8 Market snapshot
Figure9 Segment outlook-I
Figure10 Segment outlook-II
Figure11 Competitive scenario
Figure12 U.S. pharmacy market: Parent market outlook
Figure13 U.S. pharmacy market: Ancillary/related market outlook
Figure14 U.S. pharmacy market dynamics
Figure15 Market driver relevance analysis (Current & future impact)
Figure16 Estimated New Cancer Cases, 2025
Figure17 Estimated U.S. prevalence of stroke, 2021 - 2033
Figure18 Estimated U.S. prevalence of prostate cancer, 2021 - 2033
Figure19 Estimated U.S. prevalence of kidney cancer, 2021 - 2033
Figure20 Market restraint relevance analysis (Current & future impact)
Figure21 Number of pharmacy degrees conferred 2021 - 2024 by gender
Figure22 U.S. pharmacy market: Porter’s five forces analysis
Figure23 U.S. pharmacy market: PESTLE analysis
Figure24 U.S. pharmacy market: Product segment dashboard
Figure25 U.S. pharmacy market: Product market share analysis, 2025 & 2033
Figure26 Prescription market, 2021 - 2033 (USD Billion)
Figure27 OTC market, 2021 - 2033 (USD Billion)
Figure28 U.S. pharmacy market: Type segment dashboard
Figure29 U.S. pharmacy market: Type market share analysis, 2025 & 2033
Figure30 Retail pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
Figure31 Supermarket pharmacies market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
Figure32 Health system / hospital pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
Figure33 Independent pharmacies market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
Figure34 Mail-order pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
Figure35 Specialty / central fill pharmacies market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
Figure36 Long-term care and defense-related pharmacies market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
Figure37 ePharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
Figure38 Others market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
Figure39 U.S. pharmacy market: Ownership segment dashboard
Figure40 U.S. pharmacy market: Ownership market share analysis, 2025 & 2033
Figure41 Chain pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
Figure42 Independent pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
Figure43 Key company categorization
Figure44 Estimated company market share analysis, 2025

Companies Mentioned

  • Walgreens
  • CVS
  • Walmart
  • The Kroger Co.
  • Publix Pharmacy
  • Albertsons
  • Costco Wholesale Corporation
  • Kaiser Permanente
  • Amazon Pharmacy (PillPack)
  • Hims & Hers Pharmacy
  • ExactCare Pharmacy.
  • Alto Pharmacy
  • Capsule Corporation
  • BlinkRx (Blink Health)
  • Avita Pharmacy
  • Tarrytown Pharmacy Inc.
  • The Medicine Shoppe Pharmacy
  • Sullivan's Pharmacy and Medical Supply
  • Honeybee Health
  • Good Neighbor Pharmacy
  • Andrews Pharmacy
  • Dinno Health
  • Island Family Pharmacy
  • Gloyer's Pharmacy
  • Huntington Pharmacy
  • Daniel's Pharmacy
  • Apteek Pharmacy & Compounding
  • V-Care Pharmacy
  • Randol Mill Pharmacy
  • Boca Pharmacy & Home Health Center
  • Grand Avenue Pharmacy
  • Skenderian Apothecary
  • Doyle’s Pharmacy
  • Gary Drug Co
  • Care Rx Pharmacy
  • Palm Harbor Pharmacy
  • DiRx Inc.
  • Allen Family Drug
  • ScriptCo Pharmacy